Clear market notes built around the JSE, the rand, and what matters locally.

2026-10-26 14:00 • The Motley Fool Mixed Axe Cap view: Selective

The U.S. housing industry is struggling with pending home sales down 7.3% month-over-month and 11.3% year-over-year, causing investors to flee homebuilder stocks. However, Berkshire Hathaway is making significant investments in the sector, including acquiring Taylor Morrison for $6.8 billion and increasing its stake in Lennar to 11%. Berkshire CEO Greg Abel views the 10-million-home housing shortage as a long-term opportunity, though he cautions recovery won't be quick. The article suggests ordinary investors should consider buying Berkshire shares rather than directly investing in homebuilders given the volatility and patience required.

Axe note: Berkshire Hathaway is doubling down on a struggling U.S. homebuilding sector, but South African investors should think twice before following suit directly.

2026-10-26 13:53 • The Motley Fool Positive Axe Cap view: Selective

RSPH (Invesco S&P 500 Equal Weight Health Care ETF) and IBB (iShares Biotechnology ETF) offer different approaches to healthcare investing. RSPH provides broader, equal-weighted healthcare exposure with lower volatility, higher dividend yield (0.6%), and a lower expense ratio (0.4%), making it suitable for risk-averse investors. IBB offers concentrated biotech exposure with stronger recent returns (35.5% vs 31.9%) but higher volatility and drawdown risk. The choice depends on investor risk tolerance and conviction in biotechnology's momentum.

Axe note: RSPH’s steady, broad healthcare exposure suits most investors while IBB’s biotech focus demands a higher risk appetite.

2026-10-26 13:52 • The Motley Fool Positive Axe Cap view: Selective

Adobe and Docusign are compared as digital transformation leaders. Adobe demonstrates stronger growth (11.4% vs 8.2% YoY), significantly higher profitability (36.1% vs 6.9% operating margin), and now trades at a slight valuation advantage (P/S 4.1x vs 4.7x). While Docusign is pivoting to intelligent agreement management, Adobe's established scale and profitability give it an edge for investors in 2026.

Axe note: Adobe’s stronger profitability and lower valuation make it the better tech stock bet over Docusign next year.